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Incorporating induced pluripotent stem cell (iPSC) technology in regenerative medicine requires better
methods for defining and obtaining high-quality lines. Two papers in this issue of Cell Stem Cell (Buganim
et al., 2014; Wu et al., 2014) now show that H2A.X deposition can serve as a functional epigenetic marker
for distinguishing the quality of iPSCs, thus providing insights for better reprogramming methods.The process of somatic reprogramming
by defined factors occurs in a stepwise
and inefficient manner (reviewed in Papp
and Plath, 2013). Further evidence has
shown that the quality of iPSCs, which
can be determined by tetraploid comple-
mentation in mice, varies substantially.
As a result, finding reliable molecular
markers that can be used for defining
high-quality iPSCs is a prerequisite for
further clinical applications in human. Pre-
vious studies have identified that the
aberrant methylation of imprinted genes
such as Dlk-Dio3 (Stadtfeld et al., 2010)
and Zrsr1 (Chang et al., 2014)might corre-
late with the reduced pluripotency in
iPSCs; however, the reliability of tracking
these characteristics is still under debate.
Faithful reprogramming requires resetting
not only DNA methylation, but the whole
epigenetic landscape, including histone
modifications and nucleosome posi-
tioning. However, as an important aspect
of epigenetic remodeling, reassembling
of histone variants is barely understood
in iPSC induction (Banaszynski et al.,
2010). In two studies published in this
issue of Cell Stem Cell, Wu et al. (2014)
and Buganim et al. (2014) provide evi-
dence showing that the deposition
pattern of histone variant H2A.X is a
functional epigenetic marker for defining
iPSCs quality (Figure 1).
Wu and colleagues first explored the
new function of H2A.X in pluripotent
stem cells (Wu et al., 2014). They per-
formed native ChIP-seq with specific
antibodies to analyze the genome-wide
deposition pattern of H2A.X in ESCs and
MEFs. Strikingly, they found that ESC-
specific H2A.X deposition regions show
strong correlations with the silenced
extraembryonic genes targeted by Cdx2
in ESCs. They further compared the tran-
scriptome changes using Cre-mediatedH2A.X deletion from H2A.Xfloxed/floxed
ESCs and found that H2A.X deficiency
leads to upregulation of some extraem-
bryonic genes, but not the pluripotency
genes or germ layer markers. Moreover,
the newly observed function in transcrip-
tional repression was not related to
genomic instability, though H2A.X KO
leads to genome instability and deficient
DNA damage responses (Celeste et al.,
2002). H2A.X deposition seems to be crit-
ical in maintaining H3K9me3 level, but not
H3K27me3, at extraembryonic gene en-
hancers. The authors also analyzed the
H2A.X deposition pattern in iPSCs gener-
ated by a previously reported secondary
iPSC system (Stadtfeld et al., 2012) and
determined the developmental potential
of the secondary iPSCs by tetraploid
complementation. Interestingly, the iPSC
lines that were capable of tetraploid
complementation (4N+) and the ones
that failed (4N) were classified into two
distinct groups with an unsupervised
hierarchical cluster analysis of H2A.X
deposition. Moreover, the 4N iPSC lines
possess a large number of genomic
regions devoid of H2A.X deposition at a
genome-wide level, although the overall
protein levels were comparable (Figure 1).
More strikingly, the expression of extra-
embryonic genes in 4N iPSC lines
was upregulated and H3K9me3 was
decreased at the Cdx2-targeted sites of
extraembryonic genes, which was the
exact pattern in H2A.X-deficient ESCs.
They further found that H2A.X deficiency
primes ESCs and iPSCs toward extraem-
bryonic lineage differentiation in culture or
in developing embryos. Recent studies
have reported that g-H2A.X increased
during reprogramming and DNA repair
factors are required for iPSC induction
(Gonza´lez et al., 2013). Here, Wu et al.
found that the depletion of H2A.X in theCell Stem Cell 15, Ssecondary iPSC system results in greatly
reduced formation of Oct4+ colonies,
which reveals that H2A.X plays a critical
role during cellular reprogramming. Inter-
estingly, Wu et al. also observed aberrant
accumulation of H2A.X at the Dlk1-Dio3/
Chr12qF1 locus in 4N iPSC clones,
which correlates with aberrant silencing
and hypermethylation of these loci.
Buganim and colleagues focused on
the role of reprogramming factors in
determining the quality of iPSCs. They
based their work on the new combination
of factors Sall4, Nanog, Esrrb, and Lin28
(SNEL), which reprograms with low effi-
ciency compared to traditional Oct4,
Sox2, Klf4, and c-Myc (OSKM) induction.
In contrast to the OSKM combination,
they found that SNEL can produce high-
quality iPSCs at high rates as defined
by their capacity to produce healthy
‘‘all-iPSC’’ mice (Figure 1). Interestingly,
poor-quality colonies reduced when
c-Myc was excluded as a reprogramming
factor, which suggests that the interplay
between the reprogramming factors is
a crucial element in these processes.
The iPSCs were classified into three cate-
gories based on the degree of chimera
contribution and the health status
of ‘‘all-iPSC’’ mice. Multiple analyses
were performed to define the elements
dictating fully reprogrammed iPSCs.
Whole-genome transcriptional profiling,
methylome analysis, establishment of
superenhancers, single-cell analysis of
key master regulators, and global aneu-
ploidy analysis did not distinguish be-
tween poor- and high-quality iPSCs. An
interesting finding is that aberrant expres-
sion of 1,765 genes, trisomy of chromo-
some 8, and abnormal H2A.X deposition
were frequently observed in poor-quality
iPSCs that were derived from OSKM
or OSK. Unexpectedly, although botheptember 4, 2014 ª2014 Elsevier Inc. 259
Figure 1. H2A.X Deposition Distinguishes iPSC Quality
H2A.X deposition acts as a functional epigenetic marker that correlates with silenced extraembryonic
genes targeted by Cdx2 in ESCs. H2A.X deposition patterns can be used to predict higher quality iPSCs
(as determined by tetraploid complementation assay in mouse). Moreover, different combinations of
reprogramming factors can influence the deposition of H2A.X and the quality of iPSCs.
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Previewsg-H2A.X level and cell death reduced
greatly in both OSK and SNEL induction,
trisomy 8 could still be detected in OSK
iPSCs. Meanwhile, the differences in
H2A.X deposition patterns between the
high-quality OSK-iPSC lines and the
parental Oct4-GFP ESC line were still
greater than those between SNEL-iPSCs
and the same parental ESCs, which sug-
gests that trisomy of chromosome 8 and
aberrant H2A.X deposition are not only
caused by the expression of c-Myc. A
similar observation was also found in
OSSNE induction. It seems that the com-
bination of ‘‘strong’’ reprogramming fac-
tors, Oct4 and Sox2, may be responsible
for the genomic and epigenetic errors in
reprogramming. How the combination of
reprogramming factors impacts genomic
stability and epigenetic reconstruction re-
quires further investigation. Of note, the
quality of iPSCs can also be influenced260 Cell Stem Cell 15, September 4, 2014 ª2by culture conditions. For example, the
addition of Vitamin C (Stadtfeld et al.,
2012) can improve the quality of cells,
probably by facilitating epigenetic reset-
ting. Replacement of Oct4 with Tet1
in reprogramming could also generate
high-quality iPSCs without tumorigenesis
observed in the resulting all-iPSC mice
(Gao et al., 2013). All these data suggest
that faithful epigenetic reprogramming
might be a key point in the determination
of iPSCs quality. It could be extremely
important to analyze the quality and the
risk of tumorigeneity of iPSCs generated
by different reprogramming factors or
conditions.
One interesting difference between the
two studies is that Wu et al. observed
only around 100 genes expressed differ-
ently between 4N+ and 4N iPSCs using
RNA-seq, whereas Buganim et al. identi-
fied a list of 1,765 genes expressed differ-014 Elsevier Inc.ently between poor- and high-quality
iPSCs using microarray analysis. This dif-
ference might be due to different induc-
tion systems applied.
Although different induction systems
were used in these two studies, the depo-
sition of H2A.X seems to be a robust ‘‘key
marker’’ associated with pluripotency.
Unlike aberrant methylation of imprinting
genes, the deposition of H2A.X discussed
here is measured in a genome-wide
fashion and it is therefore important to
set a proper threshold similar to that in
Wu et al. It is also important to look for
more important or respective regions to
simplify the examination assay in further
applications. In the end, considering the
specific critical role of H2A.X in repressing
extraembryonic lineage differentiation, it
is important to investigate whether this
marker can be applied for defining the
quality of human iPSC lines.REFERENCES
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